Quinn
Your biopharma team, from molecule design to portfolio strategy
About Quinn
Your biopharma team, from molecule design to portfolio strategy
Company details
Funding
Last stage
Seed
Investors
Founders
Daniel Gomari
Daniel Gomari is the founder and CEO of Quinn. A Stanford postdoc and PhD in Computational Biology, his work spanned ML for drug repurposing across cancer and metabolic disease, and multi-omics studies on aging and lifespan extension. He built Quinn after watching the pharma industry make billion-dollar R&D decisions on intuition and slide decks instead of computational evidence.
LinkedInMike Snyder
Professor of Genetics at Stanford University with 900+ publications. Co-founded Quinn (developed under parent company iollo) alongside Daniel Gomari.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.